Member Info for jange

Wishing everyone in riig a happy new year and a good 2012.

St Jude Medical link and a $1.65bn Credit Suisse upgrade St Jude Medical (http://www.sjm.com/) - an important Aortech customer and a $12.3 billion market cap business - has been recently upgraded by Credit Suisse due to its successful use of a coating, marketed as ‘Optim’, which acts as the insulation for all of its pacing products. The IP to this ‘coating’ is owned by Aortech and is known as ‘Elast-Eon’. The upgrade to St Jude Medical potentially adds around $1.65bn to the market cap of this ‘MedTech’ goliath (equivalent to $5 a share). Aortech, on the other hand, has a value 1/100th of the upgrade in value of St Jude Medical. Aortech had been working with St Jude Medical for many years prior to the announcement that they made on the 20 March 2006 http://www.investegate.co.uk/Article.aspx?id=200603200700290147A This is the first official notified agreement between both companies for an initial upfront payment of $2m for the exclusive licence and supply of ‘Elast-Eon’ otherwise known as ‘Optim’. Further maintenance payments were paid over the coming two years. This was followed some years later by a further extension of the agreement by St Jude Medical on the 29 January 2009. http://www.investegate.co.uk/Article.aspx?id=200901290700114225M As more and more success was had with the ‘Optim’ coating, it was becoming clear that St Jude Medical was widening its scope for the usage of ‘Optim’ into a number of other products, as stated in my next section. Most interesting, the following Aortech RNS directly quoted a Wall Street Journal article which highlighted the success that ‘Optim’ was having. (http://www.investegate.co.uk/Article.aspx?id=201012200700152536Y), “That the company [St Jude Medical] told doctors that newer leads with a type of insulation…Optim – sold with Riata ST Optim and Durata leads – have demonstrated a better than 80% reduction in abrasion-related observations after 44 months compared with silicone leads. St Jude Medical stated that it had converted 97% of its production to ‘Optim’. St Jude Medical Product Portfolio employing ‘Optim’ technology There are quite a number of existing St Jude products that have adopted the ‘Optim’ / ‘Elast-Eon’ product. It is anticipated that there will a great deal more prospective products currently in development between St Jude and Aortech which have yet to be announced to the market. The following products currently employ ‘Optim’ / ‘Elast-Eon’: Riata® ST Optim® Defibrillation Lead Tendril® ST Optim® Pacing Lead Durata® True Bipolar, Active-Fixation Defibrillation Leads Durata® Integrated Bipolar, Active-Fixation Defibrillation Leads Durata® True Bipolar, Passive-Fixation Defibrillation Leads I

Restructuring of Board There has been a restructuring of the Aortech Board, whereby one current non-executive director – Eddie McDaid – has now moved into the executive finance director role and as previously mentioned, Bill Brown, representative of Active Capital / Bluehone investors (18.45% shareholder), was appointed in October of this year. Eddie McDaid is also a 6.91% shareholder in AorTech and was previously one of the co-founders of the business in 1992. The Scottish mafia has truly come to town and as my father used to say, wherever there is a Scotsman, there is the scent of money in the air! Certainly, from an outsider’s perspective, it appears that shareholders and management interests are now very closely aligned.

Three Reasons for share price appreciation Interestingly, there has been quite a steep increase in the share price recently, something in the region of 50%. This has been linked to three recent developments: Coming to America The company has just completed a move of its manufacturing, research and development facilities from Melbourne, Australia to Rogers in the Minneapolis / St. Paul area of Minnesota. Rogers is in the heart of what is colloquially known in the United States as ‘Central MedTech’ (or Medical Technology). There are a number of giant US based Medical Technology businesses based here – including Medtronic, 3M healthcare, EV3 Inc (now part of Covidien or Tyco Health in a previous existence), American Medical Systems and most importantly, St Jude Medical - as well as much of the ‘supply chain’ which supports these businesses. Bill was quick to explain the move “Prior to our move to Rogers in the United States, it was quite difficult for us to get the attention of new prospects, especially a number of the US ‘MedTech’ companies; we had a very long and strong relationship with St. Jude Medical and a number of European medical device manufacturers but it was not so easy for our prospective partners to visit our research and manufacturing premises in Australia. Now that we have moved, it would be fair to state that we have had a substantial increase in new US customer activity – it is now very easy for our prospective (and existing) clients to visit us and share with us some of their ideas and for us to show them what ‘Elast-Eon’ and ‘ECSil‘ can do for them. “Our business has moved onto a completely new plain and we have exciting new relationships developing. I believe that we are now able to network freely with other ‘Medtech’ companies

The Aortech business Aortech develops and commercialises a range of specialised biostable polyurethanes coatings for medical implants which have strong patent protection and are branded as ‘Elast –Eon’ and its next generation Elast-Eon™ Carbonate Silicone (ECSil). The business model is based upon; a) Attracting material supply agreements for the use of ‘Elast – Eon’ and next generation Elast-Eon™ Carbonate Silicone (ECSil) in third party medical device products; b) Attracting higher margin component manufacturing contracts using the ‘Elast- Eon’ material and next generation Elast-Eon™ Carbonate Silicone (ECSil); c) Signing up-front license, milestone and royalty deals on AorTech ‘invented’ products, namely the revolutionary and patented polymer heart valve. AorTech claim that ‘Elast-Eon’ and ‘ECSil’ have been designed to combine the biostability and flexibility of high-performance silicone rubber with the strength, tear resistance and abrasion resistance of polyurethane, to provide increased durability. This leads to improved medical device performance in terms of reduction in costs and improved component performance. AorTech expects to see the first human implantation of ECSil™ before the second half of 2012

Perhaps this is a strange title to open with, paraphrasing one of Harold MacMillan’s more famous quotes. However, when considering the following investment opportunity, existing and prospective investors in Aortech (LON:AOR) should bear in mind that the true value of this company’s equity is not ‘outed’ in the traditional P/E ratio, or discounted cashflow model. Instead, it is the strategic IP (Intellectual Property) that the company possesses and which it has built up over many years that has the true value, as a number of sizeable US and European medical technology businesses will testify to. I was very pleased to meet with Scotsman Bill Brown, recently appointed Non-Executive Director of AorTech International PLC, who, through Active Capital Trust PLC (Ticker: AIT), a listed investment trust managed by Bluehone Investors LLP, currently have an equity holding of approximately 18.45% of the business and who are one of the larger shareholders on the company register.

This is doing far better than i thought in these bad times good luck all.

Good luck all to another good week ? hopefully lol.

Another good rise today finished the week in a strong position.

Nice rise today expect good things here and not many shares on offer.

Think ill have to free something up and top up here and swap.

Drowning here.

Looks like alot of our news will be in febuary

No movement up or down at moment not a bad thing with these markets

Someone has got some faith in swap with a 35000k buy gl all

Money Swap What is Money Swap? Money Swap is a Peer-to-Peer Foreign Exchange Platform which enables individuals and businesses to trade currencies directly with each other. It thus removes the spread and margins charged by financial institutions and resulting in lower transaction costs. How do I benefit from it ? If you are a business owner/buyer and you need to pay your overseas Suppliers in US$ or Euro. You would usually send a telegraphic transfer (T/T) to your overseas Suppliers to settle the payment for your shipments of goods or services. The financial insitution will usually charge you an exchange rate for converting the currencies + commission + cable charge to effect the T/T. Money Swap provides a better exchange rate + lower commission & no cable charges ! Money Swap remits your money in the same way as the financial institutions through ‘SWIFT ‘. If you are a forex trader and you need to fund your ibfx, fxdd, ODL etc account. You would usually send a telegraphic transfer (T/T) to your overseas forex account to fund your account. The financial insitution will usually charge you an exchange rate for converting the currencies + commission + cable charge to effect the T/T. Money Swap provides a better exchange rate + lower commission & no cable charges ! Money Swap remits your money in the same way as the financial institutions through ‘SWIFT ‘. If you are a ebay users and you need to fund your paypal account. You would usually send a telegraphic transfer (T/T) to your paypal account to fund your account. The financial insitution will usually charge you an exchange rate for converting the currencies + commission + cable charge to effect the T/T. Money Swap provides a better exchange rate + lower commission & no cable charges ! Money Swap remits your money in the same way as the financial institutions through ‘SWIFT ‘. If you need to remit money to your Loved Ones overseas. You would usually send a telegraphic transfer (T/T) to your Loved Ones’ account. The financial insitution will usually charge you an exchange rate for converting the currencies + commission + cable charge to effect the T/T. Money Swap provides a better exchange rate + lower commission & no cable charges ! Money Swap remits your money in the same way as the financial institutions through ‘SWIFT ‘. Anyone who needs to send money overseas in US$ or Sterling Pounds or Euro will benefit from the cost Savings

SPOOKY LOL.

Thursday 24 November 2011 Getech is an oil services business providing gravity and magnetic data, services and geological studies to the petroleum and mining industries. It specialises in the provision of exploration data and petroleum systems, studies and evaluation. Its customers are those prospecting for, or evaluating finds of oil and minerals. The results for the year to 31 July 2011, Getech's 6th year as a public quoted company, showed the company back in the black after a difficult time in the previous year. During the period a new Chairman and a new Director of International Sales were appointed and the demand for data, services and studies continued to be strong. It was also revealed that a new contract, signed recently, could add US$ 1.1m to sales. Last year total turnover was £5.3m, up from £3.23m. Elsewhere, the Iraq agreement and the first sale of the new Russian aeromagnetic data sets give a positive view of how the business is progressing. It was also good news that the balance sheet has a net cash position. In the year ending 31 July 2011 pre-tax profits recovered from a loss of £220,000 to a pre-tax profit of £669,000. The Chairman commented that, with the increased strength of the balance sheet, the expansion of the data library and the ongoing integrated study work, he believed that a strong base for future growth was now in place. He pointed out that there had been two significant data sales after the Year End and that he anticipated positive developments in 2011/12. There seems little doubt that Getech's profits are set to advance in the current year, which ends 31 July 2012. The enhancement of top management has transformed the company. I think pre-tax profits in the current year could emerge at well over £1.5m, implying a prospective PER of less than 7. The shares look undervalued to me. I consider the shares a Buy.

Thursday 24 November 2011 The company's activities are focused on the manufacture and logistical supply of industrial fasteners. It operates both in Europe and North America. In the six months to 30 September 2011 pre-tax profits rose from £1.48m to £2.13m. This was a good result with encouraging performances from each of the firm's areas of operation. In the UK there was another strong, performance and equally strong performances in the European operations and in the USA, which achieved profitability following a restructuring of the business. Trifast is currently in the throes of acquiring a privately owned Malaysian company, Power Steel and Electro-plating, for £15m (at current exchange rates). The acquisition is being funded by an £8m share placing at 37p, with the balance being covered by an extension of the group's banking facilities with DBS Bank Ltd. The acquisition is in line with the Group's expansion plans in the Far East and looks a good fit. The Market consensus is that pre-tax profits could be set to rise to around £4.35m compared with £3.0m previously. This puts the shares on a prospective PER of around 10.9. Currently, profits are expected to grow to perhaps £4.9m in the year ending 31 March 2013. This suggests a forward PER of under 10, which is a cheap rating. I consider the shares a Buy

The board of Resources in Insurance Group plc (the "Board"), a leading provider of claims management and consultancy solutions to the UK insurance profession, is pleased to announce that it has launched a new Surety Claims Division, "RiIG Surety Claims". The UK credit hire claims market is significant and in 2009 it was estimated by The Credit Hire Organisation to be worth between £600m-£650m. In order to take advantage of potential market, RiIG Surety Claims has been formed in order to provide independent, high quality, cost-effective auditing and training services. In addition, the Board anticipate that RiIG Surety Claims will reinforces RiIG's existing in-sourced and out-sourced handling of credit hire claims for UK motor insurance providers.